REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma 97, S.R.O. (Czech Republic)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Pharma 97, S.R.O. Profile Updated: November 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Pharma 97, S.R.O. is an enterprise located in Czech Republic, with the main office in Prague. The enterprise currently operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. It was established on June 11, 1997. There are currently 1 - 5 (2024) people employed by Pharma 97, S.R.O.. The company’s latest financial report indicates a net sales revenue increase of 8.61% in 2021. Its’ total assets recorded a growth of 11.34%. The net profit margin of Pharma 97, S.R.O. decreased by 2.42% in 2021.

Headquarters
Krovinovo namesti 9/12
Prague; The City of Prague; Postal Code: 19300

Contact Details: Purchase the Pharma 97, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Pharma 97, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Pharma 97, S.R.O. report to view the information.
Registered Capital:
Purchase the Pharma 97, S.R.O. report to view the information.
Incorporation Date:
June 11, 1997
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pharma 97, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
8.61%
Total operating revenue
9.44%
Operating profit (EBIT)
-35.67%
EBITDA
-25.22%
Net Profit (Loss) for the Period
-46.44%
Total assets
11.34%
Total equity
6.34%
Operating Profit Margin (ROS)
-2.46%
Net Profit Margin
-2.42%
Return on Equity (ROE)
-5.87%
Debt to Equity Ratio
3.85%
Quick Ratio
-0.31%
Cash Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?